176 related articles for article (PubMed ID: 25551808)
1. Inhibition of matrix metalloproteinases attenuates brain damage in experimental meningococcal meningitis.
Ricci S; Grandgirard D; Wenzel M; Braccini T; Salvatore P; Oggioni MR; Leib SL; Koedel U
BMC Infect Dis; 2014 Dec; 14():726. PubMed ID: 25551808
[TBL] [Abstract][Full Text] [Related]
2. Combined therapy with ceftriaxone and doxycycline does not improve the outcome of meningococcal meningitis in mice compared to ceftriaxone monotherapy.
Ricci S; Grandgirard D; Masouris I; Braccini T; Pozzi G; Oggioni MR; Koedel U; Leib SL
BMC Infect Dis; 2020 Jul; 20(1):505. PubMed ID: 32660552
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinases contribute to the blood-brain barrier disruption during bacterial meningitis.
Paul R; Lorenzl S; Koedel U; Sporer B; Vogel U; Frosch M; Pfister HW
Ann Neurol; 1998 Oct; 44(4):592-600. PubMed ID: 9778257
[TBL] [Abstract][Full Text] [Related]
4. Closure of the blood-brain barrier by matrix metalloproteinase inhibition reduces rtPA-mediated mortality in cerebral ischemia with delayed reperfusion.
Pfefferkorn T; Rosenberg GA
Stroke; 2003 Aug; 34(8):2025-30. PubMed ID: 12855824
[TBL] [Abstract][Full Text] [Related]
5. Effect of synthetic matrix metalloproteinase inhibitors on lipopolysaccharide-induced blood-brain barrier opening in rodents: Differences in response based on strains and solvents.
Rosenberg GA; Estrada EY; Mobashery S
Brain Res; 2007 Feb; 1133(1):186-92. PubMed ID: 17184743
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of matrix metalloproteinases-2 and -9 prevents cognitive impairment induced by pneumococcal meningitis in Wistar rats.
Barichello T; Generoso JS; Michelon CM; Simões LR; Elias SG; Vuolo F; Comim CM; Dal-Pizzol F; Quevedo J
Exp Biol Med (Maywood); 2014 Feb; 239(2):225-31. PubMed ID: 24419461
[TBL] [Abstract][Full Text] [Related]
7. Role of matrix metalloproteinases in delayed neuronal damage after transient global cerebral ischemia.
Lee SR; Tsuji K; Lee SR; Lo EH
J Neurosci; 2004 Jan; 24(3):671-8. PubMed ID: 14736853
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinase (MMP)-8 and MMP-9 in cerebrospinal fluid during bacterial meningitis: association with blood-brain barrier damage and neurological sequelae.
Leppert D; Leib SL; Grygar C; Miller KM; Schaad UB; Holländer GA
Clin Infect Dis; 2000 Jul; 31(1):80-4. PubMed ID: 10913401
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinase-2 and metalloproteinase-9 activities are associated with blood-brain barrier dysfunction in an animal model of severe sepsis.
Dal-Pizzol F; Rojas HA; dos Santos EM; Vuolo F; Constantino L; Feier G; Pasquali M; Comim CM; Petronilho F; Gelain DP; Quevedo J; Moreira JC; Ritter C
Mol Neurobiol; 2013 Aug; 48(1):62-70. PubMed ID: 23479197
[TBL] [Abstract][Full Text] [Related]
10. MMP inhibition and the development of cerebrovascular atherosclerosis: The road ahead.
Napoli C
Stroke; 2002 Dec; 33(12):2864-5. PubMed ID: 12494909
[No Abstract] [Full Text] [Related]
11. Matrix metalloproteinase inhibition facilitates cell death in intracerebral hemorrhage in mouse.
Grossetete M; Rosenberg GA
J Cereb Blood Flow Metab; 2008 Apr; 28(4):752-63. PubMed ID: 17971790
[TBL] [Abstract][Full Text] [Related]
12. Melatonin decreases matrix metalloproteinase-9 activation and expression and attenuates reperfusion-induced hemorrhage following transient focal cerebral ischemia in rats.
Hung YC; Chen TY; Lee EJ; Chen WL; Huang SY; Lee WT; Lee MY; Chen HY; Wu TS
J Pineal Res; 2008 Nov; 45(4):459-67. PubMed ID: 18624955
[TBL] [Abstract][Full Text] [Related]
13. Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94.
Asahi M; Asahi K; Jung JC; del Zoppo GJ; Fini ME; Lo EH
J Cereb Blood Flow Metab; 2000 Dec; 20(12):1681-9. PubMed ID: 11129784
[TBL] [Abstract][Full Text] [Related]
14. Carcinoembryonic antigen-related cell adhesion molecule 1 inhibits MMP-9-mediated blood-brain-barrier breakdown in a mouse model for ischemic stroke.
Ludewig P; Sedlacik J; Gelderblom M; Bernreuther C; Korkusuz Y; Wagener C; Gerloff C; Fiehler J; Magnus T; Horst AK
Circ Res; 2013 Sep; 113(8):1013-22. PubMed ID: 23780386
[TBL] [Abstract][Full Text] [Related]
15. Involvement of matrix metalloproteinases-2 and -9 in the formation of a lacuna-like cerebral cavity.
Cayabyab FS; Gowribai K; Walz W
J Neurosci Res; 2013 Jul; 91(7):920-33. PubMed ID: 23606560
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotection of minocycline by inhibition of extracellular matrix metalloproteinase inducer expression following intracerebral hemorrhage in mice.
Liu Y; Li Z; Khan S; Zhang R; Wei R; Zhang Y; Xue M; Yong VW
Neurosci Lett; 2021 Nov; 764():136297. PubMed ID: 34666120
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinases in human spontaneous intracerebral hemorrhage: an update.
Florczak-Rzepka M; Grond-Ginsbach C; Montaner J; Steiner T
Cerebrovasc Dis; 2012; 34(4):249-62. PubMed ID: 23052179
[TBL] [Abstract][Full Text] [Related]
18. TLR2-induced astrocyte MMP9 activation compromises the blood brain barrier and exacerbates intracerebral hemorrhage in animal models.
Min H; Hong J; Cho IH; Jang YH; Lee H; Kim D; Yu SW; Lee S; Lee SJ
Mol Brain; 2015 Apr; 8():23. PubMed ID: 25879213
[TBL] [Abstract][Full Text] [Related]
19. Beneficial effects of Batimastat (BB-94), a matrix metalloproteinase inhibitor, in rat experimental colitis.
Di Sebastiano P; di Mola FF; Artese L; Rossi C; Mascetta G; Pernthaler H; Innocenti P
Digestion; 2001; 63(4):234-9. PubMed ID: 11435723
[TBL] [Abstract][Full Text] [Related]
20. Minocycline and hypothermia for reperfusion injury after focal cerebral ischemia in the rat: effects on BBB breakdown and MMP expression in the acute and subacute phase.
Nagel S; Su Y; Horstmann S; Heiland S; Gardner H; Koziol J; Martinez-Torres FJ; Wagner S
Brain Res; 2008 Jan; 1188():198-206. PubMed ID: 18031717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
